This article is more than 5 years old. Information may no longer be current.

Imprimis dispensing glaucoma medications on FDA drug shortage list

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Imprimis Pharmaceuticals is now dispensing preservative-free dorzolamide and a preservative-free dorzolamide/timolol formulation after dorzolamide was added to the FDA drug shortage list, the company announced in a press release.

The two glaucoma medications will not be dispensed with preservatives such as benzalkonium chloride, which is linked to adverse effects, the release said.

The drugs are available in all 50 states and Puerto Rico.